Cited by 99Angiogenesis and VEGF in CancerAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Blockade of VEGFR2 and Not VEGFR1 Can Limit Diet-Induced Fat Tissue Expansion: Role of Local versus Bone Marrow-Derived Endothelial Cells

Open access
Tam, Joshua, Duda, Dan G., Perentes, Jean Y., Quadri, Rehan S., Fukumura, Dai, Jain, Rakesh K.·2009·PLoS ONE

Abstract

BACKGROUND: We investigated if new vessel formation in fat involves the contribution of local tissue-derived endothelial cells (i.e., angiogenesis) or bone marrow-derived cells (BMDCs, i.e. vasculogenesis) and if antiangiogenic treatment by blockade of vascular endothelial growth factor (VEGF) receptors can prevent diet-induced obesity (DIO). METHODOLOGY/PRINCIPAL FINDINGS: We performed restorative bone marrow transplantation into wild-type mice using transgenic mice expressing green fluorescent protein (GFP) constitutively (driven by beta-actin promoter) or selectively in endothelial cells (under Tie2 promoter activation) as donors. The presence of donor BMDCs in recipient mice was investigated in fat tissue vessels after DIO using in vivo and ex vivo fluorescence microscopy. We investigated the roles of VEGF receptors 1 and 2 (VEGFR1/VEGFR2) by inducing DIO in mice and treating them with blocking monoclonal antibodies. We found only marginal (less than 1%) incorporation of BMDCs in fat vessels during DIO. When angiogenesis was inhibited by blocking VEGFR2 in mice with DIO, treated mice had significantly lower body weights than control animals. In contrast, blocking VEGFR1 had no discernable effect on the weight gain during DIO. CONCLUSIONS/SIGNIFICANCE: Formation of new vessels in fat tissues during DIO is largely due to angiogenesis rather than de novo vasculogenesis. Antiangiogenic treatment by blockade of VEGFR2 but not VEGFR1 may limit adipose tissue expansion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0004974

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Blockade of VEGF-R2, but not VEGF-R1, restricts AT expansion and thus prevents the progression of DIO.

    “Blockade of VEGF-R2, but not VEGF-R1, restricts AT expansion and thus prevents the progression of DIO (81)”

    From Adipose tissue remodeling and obesity (2011) · cites this paper as [81]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tam, J., Duda, D. G., Perentes, J. Y., Quadri, R. S., Fukumura, D., & Jain, R. K.
Affiliations
Harvard University (US)
Corresponding author
  • Fukumura, Dai
  • Jain, Rakesh K.
Venue
PLoS ONE
Published
2009-03-31
Volume
4
Issue
3
Pages
e4974
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2079330089
Cited by
99
References
36
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 6 · 2022: 6 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 10 · 2013: 18 · 2012: 5
FWCI
3.09
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • SERVAL (Université de Lausanne) (submittedVersion, other-oa)
Funders
  • National Institutes of Health
  • National Cancer Institute (R01CA115767, R01 CA 85140, T32CA073479, R01CA085140, R01CA096915, R24CA085140, R01-CA96915, P01CA080124, R01CA126642, P01-CA-80124)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
VEGFR2, VEGFR1, angiogenesis, vasculogenesis, diet-induced obesity, adipose tissue expansion, endothelial cells, bone marrow-derived cells, anti-angiogenic therapy, VEGF receptor blockade, adipose tissue vascularization, bone marrow transplantation
MeSH terms
Adipose Tissue, Animals, Body Weight, Bone Marrow Cells, Diet, Mice, Transgenic, Obesity, Bone Marrow Transplantation, Neovascularization, Physiologic, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factor Receptor-2, Endothelial Cells, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review